NEWS (OTCBB: BSTI) Spin Off Announced on Better Than Expected Revenue. 4948

BioShield is on Target to Meet Projected 50% Growth, With First Time Quarter
Profit
BioShield Expects to Show a Profit Less Extraordinary Items

ATLANTA, Sept. 25 -- BioShield Technologies, Inc. (OTC Bulletin
Board: BSTI) announced today that a strong fiscal 1st quarter is showing
better then expected/estimated revenue, putting the firm clearly on target
to meet its projected 50% growth rate per quarter. In addition management
stated it expects to show a profit less extraordinary items for the quarter.

BioShield's EPS has improved with each successive quarter beginning
with -$.98 in the 1st quarter of the Company's 2000 fiscal year, -$.39 in
the 2nd quarter, -$.23 in the 3rd quarter and less than -$.01 for the 4th
quarter. Management remains confident in achieving 50% growth in revenues
beyond the next few quarters, by remaining focused and increasing sales in
Europe and Asia.


    Recent company developments:

    BioShield Technologies, Inc. Announced Today That it Intends to Spin-Off
    Healthcare Network Solutions, Inc. (HNS) to Enrich Shareholders
    Value.
    http://biz.yahoo.com/prnews/010924/atm024_1.html

    Megastar Places $300,000 Order With BioShield
    http://biz.yahoo.com/prnews/010612/attu020.html

    BioShield Gets $500,000 Cash Infusion
    http://biz.yahoo.com/prnews/010606/atw021.html

    The BioShield patents covering its technology can be viewed online at:
    http://www.delphion.com/ by either conducting a search on the name
    BioShield or entering the number of the patent: US06113815, US05954869
    or US06120587.


SOURCE: BioShield Technologies, Inc.

BioShield Technologies, Inc. Announced Today That it Intends to Spin-Off
Healthcare Network Solutions, Inc. (HNS) to Enrich Shareholders Value

ATLANTA, Sept. 24  -- BioShield Technologies, Inc. (OTC Bulletin
Board: BSTI) BioShield Technologies, Inc. (BSTI) announced that it intends
to spin-off to its stockholders and on a 1 for 10 basis, a portion of those
shares owned by Healthcare Network Solutions, Inc. (HNS).
BioShield Technologies, Inc. founded HNS in April 2001 for the purpose of
providing non-medical services to physician practices. It currently owns
approximately 52% of all outstanding HNS common stock and expects to own
approximately 35% post spin-off with the difference of 17% being owned by
BioShield Technologies, Inc. shareholders.
HNS expects to file a form 10SB registration statement with the SEC later
this week at which additional information about HNS, its current and
proposed business activities and its management team may be obtained at the
SEC's website.

Safe Harbor/Forward-looking Statements
Statements in this news release that are not historical are forward- looking
statements. These forward-looking statements are subject to certain risks
and uncertainties that could cause actual results to differ materially from
those anticipated in any forward-looking statements, all of which are
difficult to predict and many of which are beyond the control of the
company, including areas such as: developing technologies; dependence on
collaborative partners; the inherent complexity and uncertainty regarding
the development of products; early-stage development of BioShield the result
of research and development efforts; future capital needs; uncertainty of
additional funding; government regulations; and other factors which are
detailed in the company's periodic reports and registration statements filed
with the Securities and Exchange Commission BioShield does not undertake to
revise or update any forward-looking statement to reflect events or
circumstances that may arise after the date hereof. BioShield is a trademark
of BioShield, Technologies, Inc.
If you have received this by error or wish to be removed from our mailing list, please go to http://removeyou.com

















BioShield is on Target to Meet Projected 50% Growth, With First Time Quarter
BioShield is on Target to Meet Projected 50% Growth, With First Time Quarter
BioShield is on Target to Meet Projected 50% Growth, With First Time Quarter
BioShield is on Target to Meet Projected 50% Growth, With First Time Quarter
BioShield is on Target to Meet Projected 50% Growth, With First Time Quarter
BioShield is on Target to Meet Projected 50% Growth, With First Time Quarter
BioShield is on Target to Meet Projected 50% Growth, With First Time Quarter
BioShield is on Target to Meet Projected 50% Growth, With First Time Quarter

Received on Wednesday, 26 September 2001 04:00:15 UTC